Introduction
The major component of the red cells in postnatal life is hemoglobin A (HbA) which consists of 2α-and 2β-globin chains (α 2 β 2 ), encoded by the α-and β-globin genes located in two different gene clusters (16p13.3 and 11p15.5, respectively) [1] . Although being embedded in markedly different chromosomal environments, both gene clusters display a strictly coordinated pattern of expression during differentiation and development [2, 3] . The human α-globin gene cluster includes the α-like globin genes arranged in the order 5′-ζ 2 -ψζ 1 -ψα 2 -ψα 1 -α 2 -α 1 -θ 1 -3′. Lying 30-70 kb upstream of the α-globin genes, four highly conserved elements (multispecies conserved sequences, MCS-R1 to 4) corresponding to erythroid-specific DNase I hypersensitive sites (HS-48, HS-40, HS-33, HS-10, respectively) act as long-range regulatory elements of the α-like globin genes [4, reviewed in 5] . Several approaches like the analysis of interspecific hybrids [6] and stable transfectants [6, 7] , studies in transgenic mice [6, 8] or in a humanized mouse model [9] , provided evidence that the major regulatory element of this gene cluster in the human locus is MCS-R2 (which corresponds to HS-40). On their own, the other elements (MCS-R1, 3, 4) seem unable to induce substantial levels of α-globin gene expression.
Genomic deletions involving the α-globin gene cluster are the most common molecular defects causing α-thalassemia (α-thal), a recessively inherited disorder characterized by a quantitative reduction of α-globin chain production leading to a mild microcytic and hypochromic anemia, HbH (β4) disease or Hb Bart's (γ4) hydrops fetales [1, 2, 10] . The spectrum of clinical severity of this condition depends on the number of α-genes being deleted, either one or two per allele, resulting in α + -thal or α 0 -thal, respectively. However, not very often, α 0 -thal may also occur due to deletion of the upstream regulatory elements resulting in a severe downregulation of the α-globin gene expression [11] [12] [13] [14] [15] .
In addition to the most common deletions (-α 3.7kb and -α 4.2 kb ), both removing only one α-globin gene, approximately 30 different large deletions (5.2 up to 115 kb) involving the α-globin gene cluster have been reported to date (http://www.globin.cse.psu.edu/hbvar/ menu.html).
Blood Cells, Molecules, and Diseases xxx (2010) xxx-xxx Usually, the molecular basis of deletional α-thal, can be readily identified by gap-PCR [16] . However, some deletions go undetected using this conventional technique. Recently, a simple methodology suitable for rapid quantitative analysis of gene dosage-multiplex ligation-dependent probe amplification (MLPA)-has been successfully applied in a number of patient samples suspected of having a large deletion in the α-globin gene cluster [17] .
Here we performed MLPA on the 16pter region screening for unknown rearrangements causing α-thal in a group of eight Portuguese patients displaying an α-thal phenotype, and presenting none of the previously described molecular defects that can be found by gap-PCR or direct sequencing. Additionally, we have analysed four patients presenting HbH disease with an unidentified molecular aetiology.
We have identified nine different deletions that remove the α-globin gene cluster and/or its distal regulatory region, four of them never reported before. One deletion occurred de novo, as demonstrated by family studies, and another one involves only the upstream regulatory element HS-40 in both alleles. These findings are a further illustration of the importance of studying naturally occurring mutants to fully understand the role of each conserved regulatory element in its native chromosome environment.
Materials and methods
Patients suspected of having α-thal were referred to our laboratories for haematological, biochemical, and DNA analysis. Red blood cell indices were obtained with a Beckman Coulter LH 750 automated cell counter (Beckman Coulter, Miami, FL, USA). Hemoglobin (Hb) analysis and HbA 2 level measurement were performed by automatic high performance liquid chromatography (HPLC; Hb-Gold; Drew Scientific Ltd, Barrow-in-Furness, Cumbria, England). HbH inclusion bodies were obtained by incubating an aliquot of whole blood for 1 h at 37°C with 1% brilliant cresyl blue in buffered saline. Genomic DNAs were isolated from peripheral leukocytes using the MagNA Pure LC (Roche Diagnostics GmbH, Mannheim, Germany). Patients in whom no abnormalities were found by gap-PCR for the five common α-thal deletions [-α 3.7 ; -α 4.2 ; -
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; -(α) 20.5 ] and for the ααα anti -α3.7 kb , were screened for point mutations in the α 2 -and α 1 -globin genes, after selective PCR amplification and sequencing in a 3130XL Genetic Analyser, ABIPRISM (Applied Biosystems, Foster City, CA, USA).
We selected for MLPA assay eight patients with a marked α-thal laboratory phenotype (MCV b 70 fL, MCH b 25 pg, normal HbA 2 level) and structurally intact α-globin genes as well as four other patients presenting HbH disease of unknown molecular basis (Table 1) .
MLPA was performed using the commercially available kit Salsa MLPA P140B HBA (MCR-Holland, Amsterdam, The Netherlands) following the manufacturer's instructions and as described elsewhere [17] . In a single MLPA reaction each patient sample (100 ng) was tested in duplicate and simultaneously with three normal controls. The amplified fragments were separated by capillary electrophoresis according to their size in the 3130XL Genetic Analyser, ABIPRISM (Applied Biosystems). Quantitative data were obtained with GeneMapper v3.7 software (Applied Biosystems, Foster City, CA, USA) and the peak areas were used, after standardization, for evaluation of copy number variation of specific genomic sequences in each sample. Since some of the deletions found removed the entire region of hybridization of commercial MLPA probes, synthetic probe design was mandatory in order to map those deletions with higher accuracy. We proceeded according to the online manufacturer's instructions (http://www.mlpa.com). Our synthetic probe mixes contained no more than 10 probes (20 oligos), three of them hybridizing to other chromosomes but the 16 (see Appendix A, Table 1 ). Standard MLPA reaction conditions were applied.
When appropriate, gap-PCR and direct nucleotide sequencing with BigDye v1.1 Cycle Sequencing Kit (Applied Biosystems) were used to identify the deletions' breakpoints. Gap-PCR for deletion (del.) VIII was achieved with primers 5'-AGAGGAGGCTAGGATGCAGGTG-3' (forward) and 5'-GGGTAAGCTGCCTTGGGCAGAGAA-3' (reverse) and PCR conditions as follows: 94°C for 5 min, 32 cycles of 94°C for 1 min, 55°C for 1 min and 72°C for 1 min, and a final extension step at 72°C for 10 min. Concerning del. IX, its breakpoints were identified by gap-PCR with primers 5'-GCACAGGGACACAGCTGGACAC-3' (forward) and 5'-GATCAGGGAGTGGGGCCAGTGG-3' (reverse) and the same above PCR conditions. All nucleotide coordinates were determined according to the GRCh37 assembly in the Ensembl Genome Browser (http:// www.ensembl.org).
To address the possibility of a de novo deletion in one of the studied cases, we used the Amp/FSTR Profiler Plus PCR amplification Kit (Applied BioSystems) to verify STRs patterns in both progenitors.
In silico analysis was performed using software available online: Clustal W 2.0.12 multiple sequence alignment tool (http://www.ebi. ac.ub/Tools/clustalw2/index.html) was used for sequence alignments, and TFSEARCH v. 1.3 tool (http://www.cbrc.jp/research/db/TFSEARCH. html) was used in the search for transcription factors consensus binding sites.
Results
In this study we selected for MLPA analysis a group of patients suspected of having α-thal based on persisting microcytic and hypochromic anemia, despite normal iron status, whose molecular basis remained uncharacterized after standard DNA analysis. Three additional cases were selected for MLPA analysis since the -α 3.7kb Table 1 Hematological, biochemical and molecular data of the patients studied. deletion found by the conventional techniques did not account for the HbH disease phenotype, suggesting the hypothesis of a large deletion in the other allele. Analysis of MLPA results revealed nine different deletions, removing the α-globin genes and/or the upstream regulatory elements known to be important for normal globin gene expression (MCS-R1-4). A schematic overview of all deletions found in this study is shown in Fig. 1A . In two individuals (Table 1 , patients A and B), the deletion found (del. I) removes all the MLPA commercial probes, therefore the whole α-globin gene cluster is deleted (Fig. 1A) . Beginning in the sub-telomeric region, this deletion has its 3'-breakpoint within a 610 kb region located between TMEM8A and SOX8 genes, as determined by the use of synthetic MLPA probes (nos. 49 and 50; Fig. 1B) . In patient C (Table 1) , another large deletion was found (del. II), slightly smaller than the first one (Fig. 1A) . It also begins in the subtelomeric region but its 3'-breakpoint lies in a 78 kb limited region, located between the synthetic probes nos. 48 and 49, within the AXIN1-TMEM8A genes region (Fig. 1B) .
Patients D and E (Table 1 ) have in common the presence of HbH, suggesting a large deficit of α-globin chains. In both, the presence of the common-α 3.7kb deletion was detected by gap-PCR. In patient D, the MLPA pattern revealed a deletion with at least 116 kb (del. III) beginning in the sub-telomeric region and extending to a 2.7 kb region between ζ 2 -globin and ψζ 1 -globin genes (its 3'-breakpoint lies between the kit probe no. 23 and the synthetic probe no. 24) (Fig. 1A and B) . In patient E, an at least 97 kb long deletion was found (del. IV) starting in the subtelomeric region and extending to a 5.7 kb region between kit probes nos. 20 and 21, downstream ψζ 1 -globin gene ( Fig. 1A and B) . In both cases the α-globin genes in cis are structurally intact. Regarding patient F (Table 1) we observed another large deletion removing the whole α-globin gene cluster (del. V; Fig. 1A ). In this case, the sub-telomeric region was intact. This deletion has about 177 kb, with its 5'-breakpoint lying within a 2.7 kb region between synthetic probes nos. 16 and 17 and its 3'-breakpoint located within a 78 kb region, between synthetic probes nos. 48 and 49, upstream the TMEM8A gene (Fig. 1B) .
Patient G (Table 1 ) was previously diagnosed with the triple α-globin gene rearrangement in one allele (ααα anti3.7 kb ). In the opposite allele we detected a deletion of ≈ 127 kb (del. VI) of which the 5'-breakpoint is located within a 13.1 kb region, before the ζ2-globin gene, between the synthetic probe no. 19 and the kit probe no. 20. Its 3'-breakpoint lies in a 27 kb region, located between the synthetic probes nos. 47 and 48, amongst RGS11 and AXIN1 genes. The MLPA kit probes nos. 29 and 39 show the boundaries of the duplicated region due to the presence of the triple α-globin gene (Fig. 1A and B) . Patient H (Table 1) is a 3-year-old girl that presents HbH. The MLPA pattern analysis revealed, in addition to the common -α 3.7kb deletion, a ≈ 30 kb deletion (del. VII) that starts 2.1 kb upstream the HS-48 site and finishes within a 13.1 kb region downstream HS-33, between synthetic probe no. 19 and the kit probe no. 20 ( Fig. 1A and  B) . This deletion does not involve the α-globin cluster, removing only its distal regulatory region. Curiously, her parents (individuals H* and H**, Table 1 ) have normal hematological indices, absence of anemia, and normal HPLC profiles. Regardless of this, we performed MLPA in her parents DNA samples. The results revealed, in the mother, heterozygosity for the -α 3.7kb deletion and in the father a normal probe pattern was found. These results suggest that a de novo mutational event had occurred in the proband. Therefore, we tested the paternity using a PCR amplification kit that co-amplifies the repeated regions of the following nine short tandem repeat loci: D3S1359, vWA, FGA, D8S1179, D21S11, D18S51, D5S818, D13S317 and D7S820. A segment of the X-Y homologous gene amelogenin is also amplified. The probability of paternity exclusion for this methodology is 99.9982% for U. S. Caucasians (AmplFSTR ® Profiler Plus TM PCR Amplification Kit; Applied BioSystems, Foster City, CA, USA). The results corroborate the parenthood and indicate that this deletion has likely arisen de novo in the proband.
In patient I (Table 1) , MLPA probe profile revealed the presence of a deletion of 86 kb (del. VIII) which breakpoints are located just upstream the C16ORF35 gene and between α 2 -and α 1 -globin genes, respectively ( Fig. 1A and B) . The breakpoint sequence was elucidated after performing gap-PCR followed by direct sequencing. It occurs in a 20nt homologous sequence (GGAGGCTGAGGCAGGAGAAT) (Fig. 2A) .
In another three cases (patients J, J* and K, Table 1 ) the MLPA profile revealed a deletion of 3.3 kb (del. IX) within the C16ORF35 gene that removes only the HS-40 site (lowering the signal of the kit probe nos. 13 and 14 and the synthetic probe no. 15 (Fig. 1A) . Patient J has HbH and presents this deletion in homozygosity (Fig. 1B) . His daughter (patient J*) and also patient K, both with a mild α-thal phenotype, have the same deletion in heterozygosity. Breakpoint characterization by gap-PCR followed by sequencing revealed that the deletion ranged from position 163793 to 167154 (3361 bp) and was replaced by an insertion of a 39 nucleotide (39nt) sequence (Fig 2B) in all three cases. All four α-globin genes are structurally intact.
Discussion
In this study, we used the MLPA methodology to screen for deletions associated to α-thal in a genomic region of approximately 950 kb (16p13.3) with a total of 50 probes. MLPA proved to be a suitable method to detect unknown and uncommon deletions and in particular, to characterize those cases which remain unsolved after performing standard molecular characterization. Initially, the use of the MLPA commercial kit allowed the screening of a ≈ 135 kb region containing the α-globin gene cluster and its distal regulatory elements (MCS-Rs). In addition, we designed a set of 24 chemically synthesized probes, extending the genomic region analysed, thus increasing the ability of MLPA to characterize distant genomic rearrangements. When appropriate, gap-PCR followed by sequencing was used for the identification of deletion breakpoints. With this approach, we were able to detect nine different deletions (Fig. 1A) , four of which had not been described before.
Large deletions involving the α-globin genes
The largest deletion described here was found in two unrelated Portuguese individuals. It starts in the 16pter region and removes all the globin distal regulatory elements as well as the complete α-globin gene cluster. We further characterized its 3' region possible involved in the ATR-16 syndrome. This is defined as a contiguous gene syndrome resulting from haploinsufficiency of the α-globin gene cluster and of genes involved in mental retardation. The genomic region associated with this phenotype was narrowed to an 800 kb region [18] encompassing the SOX8 gene, generally assumed to be the candidate gene for the syndrome. Conversely, a deletion of the tip of chr16p including the SOX8 gene was recently described as not being associated with dysmorphic features or mental retardation [19] . We found that del. I has its 3'-breakpoint located somewhere between TMEM8A and SOX8 genes, therefore resembling the previously described -GZ deletion which has its 3'-breakpoint within a region of 31 kb between 869 and 900 kb from the telomere [17, 18] . In both cases, SOX8 gene remains intact, and deletions are only associated with the α-thal phenotype. Del. II also begins in the sub-telomeric region of chr16 but has its 3' breakpoint within a 78 kb region between the genes AXIN1 and TMEM8A. Here we found similarity with the previously described -AB deletion [17] but since the latter occurred de novo, del. II probably resulted from another mutational event and might be a different deletion. In this case, further refined mapping could contribute for their differentiation.
Two other deletions found (del. V and VI) have some features in common. Both begin in the C16ORF35 gene, leaving the sub-telomeric region intact, and finish downstream the 3'HVR of the α-globin cluster, removing all the structural genes and their distal regulatory Remarkably, the conjugation of these two defects origins an unusual MPLA pattern (Fig. 1B.VI) . Both del. V and VI present no similarity with others already described and therefore we considered them as novel, named -ABT and -LSB respectively, according to the place of origin of the Portuguese patients (ABT-Abrantes and LSB-Lisboa). The other novel deletion found (del. VIII) has 86 kb, starts just upstream of the C16ORF35 gene and finishes between α 2 -and α 1 -globin genes, leaving the latter intact. It was originated by a homologous recombination event occurring in a 20nt sequence present in both breakpoint regions ( Fig. 2A) . We named this deletion as (αα) QLZ (QLZ-Queluz).
Deletions removing only the distal regulatory elements
Naturally occurring deletions that remove the region upstream of the α-globin gene cluster, therefore eliminating the distal regulatory elements, are sporadic but characterize a particular category of α-thal determinants in which the α-globin genes are physically intact but functionally inactive. In humans, although four MCSs are considered, only the absence of MCS-R2 has proven, by experimental assays, to be sufficient to downregulate α-globin gene expression to less than 3% of normal [7] . Consequently, it has been regarded as the major regulatory element of this globin gene cluster.
Since the first observation that naturally occurring deletions of these regulatory elements abolish expression of their remote target genes [11] ZW [14] , the hypothesis of the crucial importance of HS-40 has remained unproven in the native human chromosome environment.
In this study, we have identified four of this sort of deletions. Two of them are large deletions (del. III and del. IV) which equally start in the sub-telomeric region but have different 3'-breakpoints in the beginning of the α-globin cluster. Regarding del. III, it is located between ζ 2 and ψζ 1 , probably within the inter-ζHVR region, which has Alu rich repetitive sequences frequently found at deletion breakpoints. Consequently, del. III resembles the previously described (αα) CMO deletion [20] . In case of del. IV, the 3'-breakpoint is located upstream the ζ 2 gene and it seems analogous with the previously described (αα) MM deletion [12] . Since the father of patient E is from the Azores Islands, the same islands where MM patient came from, we are probably detecting another case of the same mutational event. Accordingly, both patients (D and E) present HbH. This is the result of the co-inheritance of one of these large deletions (a functional α 0 -thal allele) with the common -α 3.7kb deletion in the other allele, causing a marked deficit of α-globin chains that gives rise to β4 tetramer formation.
In patient H (that also presents HbH) a de novo deletion of ≈ 30 kb was found, eliminating HS-48, HS-40 and HS-33, leaving intact the HS-10 site. This element, alone, is unable to enhance the downstream α-globin genes expression giving rise to an α 0 -thal allele. The coinheritance, in the other allele, of the -α 3.7kb deletion justifies the presence of HbH inclusion bodies. This novel deletion was named (αα) CSC (CSC-Cascais). As in the majority of the cases described in the literature, this deletion removes several HS sites simultaneously, and does not help to define the minimal region thought to be necessary for downstream α-globin gene expression in the human background. However, we found in three individuals a small deletion of 3.3 kb (del. IX) within the C16ORF35 gene that removes only the HS-40 site. One of them (patient J) presents the deletion in homozygosity (Fig. 1B.IX) , associated with Hb H disease. His daughter (patient J*) presents the deletion in heterozygosity associated with a mild α-thal phenotype. Patient K came from the same Portuguese region (Alentejo) as patient J and has an α-thal phenotype. Remarkably, the deletion of the HS-40 site is replaced by an insertion of 39nt (Fig. 2B ) whose sequence is not found in the human genome (http://www.ncbi.nlm.nih.gov/blast/ BLAST.cgi). Interestingly, very recently, an Australian immigrant case was described, presenting this same deletion/insertion rearrangement pattern in one allele [15] . Although the 39nt sequence was not reported, and given the rarity of this kind of events, we presume that Deletion breakpoints are highlighted with ▼.
it was the same rearrangement described here. Since we have three Portuguese cases (two confirmed relatives and one living in the same geographical area) and the fourth one was described in an Australian Caucasian immigrant, we consider highly probable that they are the result of the same mutational event originated in Alentejo, Portugal. Consequently, this deletion was named (αα) ALT . Assuming that HS-40 is crucial for downstream gene expression, its deletion is sufficient to cause a severe α-globin chain imbalance, possibly with life threatening consequences. If so, and keeping in mind our HbH homozygous patient (J), we hypothesized that this 39nt orphan sequence might resemble a functionally important motif inside HS-40 and therefore, could be responsible for the small but life-compatible levels of α-globin chain synthesis. The results of local sequence alignment revealed some resemblance to the HS-40 site but with a low alignment score (Fig. 3A) . Nevertheless, the search for transcription factor binding sites within this 39nt fragment was somewhat more informative (Fig. 3B) . Although the scores obtained for the delHS-40 + 39nt rearrangement were lower than those corresponding to the wild-type sequence, we acknowledge the reconstruction of the Sp1 transcription factor binding site with a similar score to that found in the normal HS-40 sequence. This Sp1 site has been reported to be essential for this element regulatory function [21] [22] [23] . Without further functional studies, we cannot exclude a possible long-distance regulatory role of this 39nt inserted sequence. In contrast, if this rearrangement has no functional significance, we have to assume that the other HS-sites, either alone or together with other genomic regions, may be sufficient to enable life compatible amounts of α-globin chain synthesis in the human background.
As far as we know, our patient J and the patient reported by Sollaino et al [24] presenting a 7 kb deletion, are the only two reported cases with a naturally occurring homozygous HS-40 deletion associated with a severe downregulation of the α-globin genes expression, resulting in a phenotype of HbH disease. It had been previously reported that, in cell lines carrying the HS-40 deletion, the basal levels of α 1 -and α 2 -globin mRNA were less than 3% of the control [7] . Also, for instance, in a humanized mouse model it was proven that the expression of α-globin genes and all of the long-range interactions depend largely on just one of the HSs, the HS-40. Removal of this element results in loss of all the interactions and α-globin expression [9] . However, the hematological and clinical features of these two rare cases of HbH disease confirm that the complete loss of HS-40 region severely downregulates the expression of the α-globin genes, but is not associated with a complete absence of α-mRNA and α-chain production.
Regarding the α-globin gene cluster and since most of the research has been carried out in cell lines and in mice, these naturally occurring small deletions involving only one MCS have a clear potential for a better understanding of the role of these elements in the native human chromosome environment and hopefully contribute to the comprehension of how they operate in the human background.
